NeoPharm CO., LTD.

A092730

KR7092730001

Personal Products

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-28 pm EDT			5-day change	1st Jan Change
25,450 ^KRW	-1.17%		+9.46%	-1.55%

2023	NeoPharm CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
2019	NeoPharm CO., LTD. announced that it has received KRW 31.970667276 billion in funding	CI

NeoPharm CO., LTD. announced that it has received KRW 31.970667276 billion in funding

June 02, 2019

On June 3, 2019, NeoPharm CO., LTD. (KOSDAQ:A092730) closed the transaction.

Latest news about NeoPharm CO., LTD.

NeoPharm CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
NeoPharm CO., LTD. announced that it has received KRW 31.970667276 billion in funding	19-06-02	CI
NeoPharm CO., LTD. announced that it expects to receive KRW 31.970667276 billion in funding	19-05-23	CI
Gpower, inc. cancelled the acquisition of 0.27% stake in NeoPharm Co., Ltd. from Byungduk Park.	18-12-03	CI
Gpower, inc. agreed to acquire 0.27% stake in NeoPharm Co., Ltd. from Byungduk Park for approximately KRW 780 million.	17-12-07	CI
HOPE BIOSCIENCES, INC. Acquires Worldwide Rights to Novel MERTK/AXL Inhibitor from Neopharm Co. Ltd	17-02-01	CI
Han Bul Cosmetics Co., Ltd. and an individual completed the acquisition of 29.39% stake in Neopharm Co Ltd from Ahn, Yong-Chan and 7 individuals.	16-06-22	CI
Han Bul Cosmetics Co., Ltd. and an individual signed a contract to acquire 29.39% stake in Neopharm Co Ltd from Yong-Chan Ahn and 7 individuals for KRW 72.8 billion.	15-12-06	CI
Neopharm Co Ltd(KOSDAQ:A092730) added to S&P Global BMI Index	15-09-21	CI
LEO Pharma A/S Enters Supply and Distribution Agreement with NeoPharm Co., Ltd. on Non-Prescription Skin Care Solutions	15-06-03	CI
Neopharm Co Ltd's Equity Buyback announced on February 10, 2014 has expired.	15-02-08	CI
Tranche Update on Neopharm Co Ltd's Equity Buyback Plan announced on February 10, 2014.	14-05-11	CI
Neopharm Co Ltd authorizes a Buyback Plan.	14-02-09	CI
Neopharm Co Ltd announces an Equity Buyback for KRW 1,000 million worth of its shares.	14-02-09	CI
Tranche Update on Neopharm Co Ltd's Equity Buyback Plan announced on July 9, 2013	13-10-13	CI
Neopharm Co Ltd s Equity Buyback announced on July 9, 2013 has expired with 166,483 shares for KRW 1,007.08 million.	13-10-09	CI
Neopharm Co Ltd announces an Equity Buyback	13-07-08	CI

NeoPharm Co., Ltd. is a Korea-based company engaged in the manufacture of cosmetics. The Company produces its products under brand names of ATOPALM, including daily care, intensive care, special care and baby care products; Derma:B, including foam cleansers, oil cleansers, toners, emulsions, creams, facial masks, blemish base (BB) creams, sun protectors, white watering serums, anti-aging eye creams and others; ZEROID, including creams and lotions for recovering damaged skin barriers and hypollalergenic foaming cleansers for atopy and sensitive skins, and others. It also engages in the original equipment manufacturing (OEM) of skin drugs.

Sector

Personal Products

Calendar

2024-05-09 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for NeoPharm CO., LTD.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Cosmetics & Perfumes

	1st Jan change	Capi.
NEOPHARM CO., LTD.	-1.55%	146M
KAO CORPORATION	+10.09%	18.86B
GALDERMA GROUP AG	0.00%	17.37B
SHISEIDO COMPANY, LIMITED	-1.32%	10.65B
COTY INC.	-7.81%	10.26B
AMOREPACIFIC CORPORATION	+7.52%	6.72B
PROYA COSMETICS CO.,LTD.	+10.34%	5.94B
NATURA &CO HOLDING S.A.	+0.06%	4.55B
INTER PARFUMS, INC.	-19.01%	3.83B
INTERPARFUMS	-3.97%	3.48B

Cosmetics & Perfumes

NeoPharm CO., LTD.

Equities

A092730

KR7092730001

Personal Products

NeoPharm CO., LTD. announced that it has received KRW 31.970667276 billion in funding

Latest news about NeoPharm CO., LTD.

Chart NeoPharm CO., LTD.

Company Profile

Income Statement Evolution

Ratings for NeoPharm CO., LTD.

EPS Revisions

Quarterly revenue - Rate of surprise

Sector Cosmetics & Perfumes